Vir Biotechnology, Inc. (VIR) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

0Shares Outstanding

4,944,467Shares held by institutions

$41,830,191Value of institutional holdings

90.46%Institutional ownership %

37.86%Shares Changed QoQ

211No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

Vir Biotechnology, Inc. (NASDAQ:VIR) showed up in the 13F filings of 214 institutional investors as of December 2025.

Collectively, these holders controlled 83.0% of Vir Biotechnology's outstanding shares in December 2025, up from 78.2% in September 2025.
They increased total shares held in VIR by 7.87% quarter over quarter, and investors in Vir Biotechnology increased 2.88% from a year ago.
During the quarter, 97 of these 214 funds increased positions in VIR, 77 reduced exposure, and 40 held steady.
Altogether, these fund groups held 115.24Mn shares in VIR by December 2025, up by 8.41Mn shares quarter on quarter, and up 24.45Mn shares year over year.
As of December 31, 2025, the biggest holder of Vir Biotechnology is BlackRock, Inc. at 16.33Mn shares, representing 11.75% of shares outstanding.
Leading buyers of Vir Biotechnology shares for the quarter ending December 2025 were GSK plc (8.55Mn), BALYASNY ASSET MANAGEMENT L.P. (1.37Mn), Candriam S.C.A. (1.03Mn), State Street Corp (988.26K), GordonMD Global Investments LP (930.32K).
The largest sales of VIR for the quarter ending December 2025 came from SB INVESTMENT ADVISERS (UK) LTD (3.57Mn), Royal Bank Of Canada (711.64K), RENAISSANCE TECHNOLOGIES LLC (552.64K), Hudson Bay Capital Management LP (498.76K), Jpmorgan Chase & Co (480.43K).
Per Business Quant, the top 10 investors in VIR for the quarter ending December 2025 include BlackRock, Inc. (16.33Mn), SB INVESTMENT ADVISERS (UK) LTD (13.12Mn), ARCH Venture Management, LLC (12.92Mn), VANGUARD GROUP INC (12.55Mn), GSK plc (8.55Mn), State Street Corp (6.23Mn), FMR LLC (3.16Mn), Morgan Stanley (2.68Mn), DIMENSIONAL FUND ADVISORS LP (2.54Mn), ORBIMED ADVISORS LLC (2.38Mn).

214 Institutional Holders

4,944,467 Total Shares Held

Rows:

Download Data

Owner Name	Date	Change (QoQ)	Change (%)	Value (USD)
BlackRock, Inc.	31 Dec, 2025	362,447	2.27%	$0.00
ARCH Venture Management, LLC	31 Dec, 2025	0	0.00%	$0.00
SB INVESTMENT ADVISERS (UK) LTD	31 Dec, 2025	-3,567,064	-21.38%	$0.00
Barclays Plc	31 Dec, 2025	-594,766	-61.92%	$0.00
VANGUARD GROUP INC	31 Dec, 2025	-250,437	-1.96%	$0.00
Aberdeen Group plc	31 Dec, 2025	-135,688	-8.89%	$0.00
HSBC HOLDINGS PLC	31 Dec, 2025	4,225	7.34%	$0.00
GSK plc	31 Dec, 2025	8,550,954	0.00%	$0.00
GordonMD Global Investments LP	31 Dec, 2025	930,317	0.00%	$0.00
Rockefeller Capital Management L.P.	31 Dec, 2025	49,341	474.57%	$0.00
State Street Corp	31 Dec, 2025	988,262	18.86%	$0.00
Boxer Capital Management, LLC	31 Dec, 2025	625,000	0.00%	$0.00
FMR LLC	31 Dec, 2025	-478,714	-13.16%	$0.00
Clarius Group, LLC	31 Dec, 2025	-11,112	-1.79%	$0.00
Morgan Stanley	31 Dec, 2025	-9,973	-0.37%	$0.00
Ikarian Capital, LLC	31 Dec, 2025	-17,662	-2.98%	$0.00
DIMENSIONAL FUND ADVISORS LP	31 Dec, 2025	-442,594	-14.86%	$0.00
Nuveen, LLC	31 Dec, 2025	360,064	175.23%	$0.00
ORBIMED ADVISORS LLC	31 Dec, 2025	0	0.00%	$0.00
Corient Private Wealth LLC	31 Dec, 2025	263,217	101.36%	$0.00

1 - 20 of 214

Research Tools